A hypothesis on the role of insulin-like growth factor I in testicular germ cell tumours

Medical Hypotheses

Volumn 63, Issue 3, 2004, Pages 511-514

  Zavos, Christos ^a,b   Andreadis, Charalampos ^a   Diamantopoulos, Nikolaos ^a   Mouratidou, Despina ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b 553 37 Thessaloniki Macedonia G ^*  (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ACROMEGALY; ARTICLE; BODY HEIGHT; BRAIN CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; GERM CELL TUMOR; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPOTHESIS; LUNG CANCER; MALE; NEOVASCULAR GLAUCOMA; ONCOGENE; PATHOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROSTATE CANCER; TESTIS TUMOR;

ANIMALS; CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; GERM CELLS; GERMINOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MODELS, BIOLOGICAL; TESTICULAR NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 3342983217     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.02.035     Document Type: Article

References (29)

1. Bosl GJ, Bajorin DF, Sheinfeld J, et al. Cancer of the testis. In: DeVita VT, Hellman S, Rosenberg SA, editor. Cancer: principles and practice of Oncology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2001. p. 1491-518
2. Dieckmann K.P., Pichlmeier U. Is risk of testicular cancer related to body size? Eur. Urol. 42:2002;564-569
3. Bergstrom R., Adami H.O., Mohner M., et al. Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon. J. Natl. Cancer Inst. 88:1996;727-733
4. Akre O., Ekbom A., Sparen P., Tretli S. Body size and testicular cancer. J. Natl. Cancer Inst. 92:2000;1093-1096
5. Daughaday W.H. The possible autocrine/paracrine and endocrine roles of insulin-like growth factors of human tumors. Endocrinology. 127:1990;1-4
6. Lincoln D.T., Sinowatz F., Temmim-Baker L., Baker H.I., Kolle S., Waters M.J. Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells. Histochem. Cell Biol. 109:1998;141-159
7. Bustin S.A., Jenkins P.J. The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol. Med. 7:2001;447-454
8. Li L., Yu H., Schumacher F., Casey G., Witte J.S. Relation of serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 to risk of prostate cancer (United States). Cancer Causes Control. 14:2003;721-726
9. Kaaks R., Lundin E., Rinaldi S., et al. Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control. 13:2002;307-316
10. Zumkeller W. IGFs and IGF-binding proteins as diagnostic markers and biological modulators in brain tumors. Expert Rev. Mol. Diagn. 2:2002;473-477
11. Spitz M.R., Barnett M.J., Goodman G.E., Thornquist M.D., Wu X., Pollak M. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Cancer Epidemol Biomarkers Prev. 11:2002;1413-1418
12. Swerdlow A.J., Higgins C.D., Adlard P., Preece M.A. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet. 360:2002;273-277
13. Marek B., Kajdaniuk D., Kos-Kudla B., Ostrowska Z., Niedziolka D., Janczewska-Kazek E. Acromegaly and the risk of cancer. Pathophysiology. 8:2001;69-75
14. Colao A., Marzullo P., Spieza S., Lombardi G. Acromegaly and prostate cancer. Growth Horm. IGF Res. 10(Suppl A):2000;S37-S38
15. Stoving R.K., Hangaard J., Hagen C., Flyvbjerg A. Low levels of the 150-kD insulin-like growth factor binding protein 3 ternary complex in patients with anorexia nervosa: effect of partial weight recovery. Horm. Res. 60:2003;43-48
16. Le Roith D. Regulation of proliferation and apoptosis by the insulin-like growth factor I receptor. Growth Horm. IGF Res. 10(Suppl A):2000;S12-S13
17. Cohen P., Lamson G., Okajima T., Rosenfeld R.G. Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth. Mol. Endocrinol. 7:1993;380-386
18. Oh Y., Muller H.L., Pham H., Rosenfeld R.G. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J. Biol. Chem. 268:1993;26045-26048
19. Kountouras J., Zavos C., Chatzopoulos D. Apoptosis in hepatitis C. J. Viral Hepat. 10:2003;335-342
20. Kountouras J., Kouklakis G., Zavos C., et al. Apoptosis, inflammatory bowel disease and carcinogenesis: overview of international and Greek experiences. Can. J. Gastroenterol. 17:2003;249-258
21. Parrizas M., LeRoith D. Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology. 138:1997;1355-1358
22. Butt A.J., Firth S.M., Baxter R.C. The IGF axis and programmed cell death. Immunol. Cell Biol. 77:1999;256-262
23. Akagi Y., Liu W., Zebrowski B., Xie K., Ellis L.M. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. Cancer Res. 58:1998;4008-4014
24. Dunn S.E., Ehrlich M., Sharp N.J., et al. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res. 58:1998;3353-3361
25. Villalpando I., Lopez-Olmos V. Insulin-like growth factor I (IGF-I) regulates endocrine activity of the embryonic testis in the mouse. J. Steroid Biochem. Mol. Biol. 86:2003;151-158
26. Cailleau J., Vermeire S., Verhoeven G. Independent control of the production of insulin-like growth factor I and its binding protein by cultured testicular cells. Mol. Cell Endocrinol. 69:1990;79-89
27. Drescher B., Lauke H., Hartmann M., Davidoff M.S., Zumkeller W Immunohistochemical pattern of insulin-like growth factor (IGF) I IGF II and IGF binding proteins 1 to 6 in carcinoma in situ of the testis. Mol. Pathol. 50:1997;298-303
28. Bernini G., Sgro M., Bartolommei A., et al. Retroperitoneal seminoma secondary to 'burned out' testicular tumor in an acromegalic patient. Eur. J. Surg. Oncol. 18:1992;191-194
29. Ochsenkuhn R., Pfaffle R., Nieschlag E. Seminoma in a 31-year-old patient on long-term growth hormone therapy. Exp. Clin. Endocrinol Diabetes. 107:1999;386-388